Fig. 1: Clinical outcomes of patients with MRD-positive B-ALL after CD19/CD22 bispecific CAR-T cells.

The bar chart shows the clinical response and follow-up of patients during CAR-T therapy. Each bar represents an individual patient and the study number. The different colors represent different disease status.